Fully functional, naturally occurring and C-terminally truncated variant human immunodeficiency virus (HIV) Vif does not bind to HIV Gag but influences intermediate filament structure

Journal of General Virology

Volumn 82, Issue 3, 2001, Pages 561-573

  Henzler, T ^a   Harmache, A ^a   Herrmann, H ^a   Spring, H ^a   Suzan, M ^a   Audoly, G ^a   Panek, T ^a   Bosch, V ^a  

^a Forschungsschwerp Angew Tunorvir   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTISERUM; BINDING PROTEIN; CELL MEMBRANE PROTEIN; CYTOSKELETON PROTEIN; DETERGENT; GAG PROTEIN; GENE PRODUCT; MICROTUBULE PROTEIN; PLECTIN; TUBULIN; VIF PROTEIN; VIMENTIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELL STRAIN; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; GENE FUNCTION; GENETIC CODE; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MICROFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS; SOLUBILITY; STRAIN DIFFERENCE; VIRUS GENE; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0035116505     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-82-3-561     Document Type: Article

References (46)

1. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone
2. Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of Vif for optimal infectivity: Functional difference between Vif and Nef
3. Human immunodeficiency virus type 1 Vif-mutant particles from restrictive cells: Role of Vif in correct particle assembly and infectivity
4. Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site
5. Gag precursor
6. Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton
7. Feline immunodeficiency virus Vif localizes to the nucleus
8. Interaction of frog virus 3 with the cytomatrix. IV. Phosphorylation of vimentin precedes the reorganization of intermediate filaments around the virus assembly sites
9. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: Definition of critical amino acids involved in cell tropism
10. Peripheral blood mononuclear cells produce normal amounts of defective Vif-human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps
11. HIV-1 auxiliary proteins: Making connections in a dying cell
12. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions
13. Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network
14. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins
15. Subcellular localization of the Vif protein of human immunodeficiency virus type 1
16. Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains
17. Intermediate filaments and their associates: Multi-talented structural elements specifying cytoarchitecture and cytodynamics
18. Temperature-sensitive intermediate filament assembly. Alternative structures of Xenopus laevis vimentin in vitro and in vivo
19. Role of Vif during packing of the core of HIV-1
20. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein
21. Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro
22. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein
23. Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells
24. Interaction of Theiler's virus with intermediate filaments of infected cells
25. Unimpaired function of a naturally occurring C-terminally truncated vif gene product of human immunodeficiency virus type 1
26. Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non-permissive' T lymphoid cells stably infected with selectable HIV-1
27. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions
28. Transfer of endoplasmic reticulum and Golgi retention signals to human immunodeficiency virus type 1 gp160 inhibits intracellular transport and proteolytic processing of viral glycoprotein but does not influence the virus particle budding
29. Immunogold EM reveals a close association of plectin and the desmin cytoskeleton in human skeletal muscle
30. Tryptophan 95, an amino acid residue of the caprine arthritis-encephalitis virus Vif protein which is essential for virus replication
31. Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes
32. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes
33. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells
34. Evidence for a newly discovered cellular anti-HIV-1 phenotype
35. The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: A role for Vif in determining virus host range and cross-species transmission
36. Vif and the p55(Gag) polyprotein of human immunodeficiency virus type 1 are present in colocalizing membrane-free cytoplasmic complexes
37. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1
38. The env gene variability is not directly related to the high cytopathogenicity of an HIV-1 variant
39. Identification of the cytolinker plectin as a major early in vivo substrate for caspase-8 during CD95- and tumor necrosis factor receptor-mediated apoptosis
40. The HIV ′A′ (sor) gene product is essential for virus infectivity
41. Molecular biology of the human immunodeficiency virus accessory proteins
42. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells
43. Role of adenovirus E1B proteins in transformation: Altered organization of intermediate filaments in transformed cells that express the 19-kilodalton protein
44. Antigenic domains of the HIV-1 vif protein as recognized by human sera and murine monoclonal antibodies
45. In vivo genetic variability of the HIV-1 vif gene
46. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4